Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4

Benzinga Newsdesk www.benzinga.com Negative 92.3%

Neg 92.3% Neu 0% Pos 0%

Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $2.15 to $1.4.